These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Hirt-Minkowski P, Dickenmann M, Schifferli JA. Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363 [Abstract] [Full Text] [Related]
3. Posttransplant recurrence of atypical hemolytic uremic syndrome. Valoti E, Alberti M, Noris M. J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880 [Abstract] [Full Text] [Related]
10. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Frémeaux-Bacchi V, Steiger J. Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317 [Abstract] [Full Text] [Related]
11. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric Nephrology. J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974 [Abstract] [Full Text] [Related]
13. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Lee BH, Kwak SH, Shin JI, Lee SH, Choi HJ, Kang HG, Ha IS, Lee JS, Dragon-Durey MA, Choi Y, Cheong HI. Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976 [Abstract] [Full Text] [Related]
14. aHUS caused by complement dysregulation: new therapies on the horizon. Waters AM, Licht C. Pediatr Nephrol; 2011 Jan; 26(1):41-57. PubMed ID: 20556434 [Abstract] [Full Text] [Related]
15. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS). Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L. Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822 [Abstract] [Full Text] [Related]
16. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Richards A, Kathryn Liszewski M, Kavanagh D, Fang CJ, Moulton E, Fremeaux-Bacchi V, Remuzzi G, Noris M, Goodship TH, Atkinson JP. Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452 [Abstract] [Full Text] [Related]
17. Complement disorders and hemolytic uremic syndrome. Joseph C, Gattineni J. Curr Opin Pediatr; 2013 Apr; 25(2):209-15. PubMed ID: 23399570 [Abstract] [Full Text] [Related]
18. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP. J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990 [Abstract] [Full Text] [Related]
20. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Tran H, Chaudhuri A, Concepcion W, Grimm PC. Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]